Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Raw Materials (2020 - 2025)

Historic Raw Materials for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $16.0 million.

  • Maravai Lifesciences Holdings' Raw Materials fell 381.04% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 381.04%. This contributed to the annual value of $17.0 million for FY2024, which is 1222.46% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Raw Materials is $16.0 million, which was down 381.04% from $16.4 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Raw Materials high stood at $26.8 million for Q3 2023, and its period low was $13.5 million during Q4 2022.
  • In the last 5 years, Maravai Lifesciences Holdings' Raw Materials had a median value of $18.5 million in 2021 and averaged $19.0 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Raw Materials skyrocketed by 7751.98% in 2021, and later crashed by 3778.7% in 2024.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Raw Materials stood at $19.7 million in 2021, then crashed by 31.63% to $13.5 million in 2022, then soared by 43.39% to $19.3 million in 2023, then decreased by 12.22% to $17.0 million in 2024, then dropped by 5.56% to $16.0 million in 2025.
  • Its Raw Materials stands at $16.0 million for Q3 2025, versus $16.4 million for Q2 2025 and $17.2 million for Q1 2025.